Anticholinergic Drug Burden in Older People's Brain - How well is it Measured?
Cited by (112)
Items 101–112 of 112
- Anticholinergic therapy: A case-based approachDudley Robinson, George Araklitis · 2019 · Case Reports in Women s Health
- Fármacos con carga anticolinérgica: aspectos prácticos y precaucionesÁngela María Villalba-Moreno, Eva Rocío Alfaro Lara, Susana Sánchez‐Fidalgo · 2020 · FMC - Formación Médica Continuada en Atención Primaria
- Potentially inappropriate prescribing according to STOPP-2 criteria among elderly patients in an acute medical department: An observational study of prevalence, predictive factorsAmal Mrani Alaoui, Oumaima Elqabissi, Salma Loutfi, Aicha Chaibi, Rhita Nechba Bennis, Jihane Belayachi, Naoufel Madani, Rédouane Abouqal · 2021 · Therapies
- PENGARUH DURASI PENGGUNAAN OBAT ANTIKOLINERGIK TERHADAP KOGNITIF PASIEN LANJUT USIA DI RAWAT JALANPradhani Dhaneswari, I Dewa Putu Pramantara, Fita Rahmawati · 2021 · JURNAL FARMASI DAN KESEHATAN INDONESIA
- Psychopharmacology in late life: Key challenges and opportunitiesShubham Ramdas Mule, Vinayak Pawar, Muktika Tekade, Nupur Vasdev, Tanisha Gupta, Amrita Singh, Satyajit Dey Sarker, Rakesh Kumar Tekade · 2024 · Elsevier eBooks
- The REGENERATE Study: A Non-Randomized Feasibility Study of an Intervention to REduce anticholinerGic burdEN in oldER pATiEntsAthagran Nakham, Christine M Bond, Moira Cruickshank, Rumana S. N. Newlands, Phyo Kyaw Myint · 2024 · Geriatrics
- Evaluatie van de informatiebronnen voor het bewaken van anticholinerge effecten in de farmacotherapieE. MATTON, I. DE MEESTER, Hans De Loof · 2025 · Tijdschrift voor Geneeskunde
- Additional file 1 of Adverse drug reactions associated with amitriptyline — protocol for a systematic multiple-indication review and meta-analysisBrueckle, Maria-Sophie, Thomas, Elizabeth T., Seide, Svenja E., Maximilian Pilz, Ana Isabel González-González, Truc Sophia Nguyen, Sebastian Harder, Paul Glasziou, Ferdinand Michael Gerlach, Christiane Muth · 2020 · Figshare
- Antimuscarinic medication used for the treatment of overactive bladder in women and the risk of cognitive decline, cardiovascular disease and mortality—a systematic reviewTurlough Maguire, Calum Marr, Heather Barry, Mohamed Abdel‐Fattah, Bernadette McGuinness · 2026 · Age and Ageing
- Impact de la réduction de la charge anticholinergique sur les symptômes comportementaux et psychologiques de la démence chez les patients âgésYacine Jaïdi · 2020
- Could anticholinergics accelerate ALS progression? A critical perspective on drug safety and disease vulnerabilityTiffany R. Price, Chia‐Yuan Chang, Kirya Skinner, Michael Dinneny, Parmida Nafezi, Lisa Kuramoto, Mary A. De Vera, Neil R. Cashman, Jacquelyn J. Cragg · 2026 · Expert Opinion on Drug Safety
- Anticholinergic burden in the German National Cohort (NAKO): Patterns of anticholinergic drug exposure and utilizationJulie K. Könnecke, Nele L. Bößneck, Alexandra Drebka, Annika J. Scholl, Miriam Degen, Nina Ebert, Margit Heier, Thomas Keil, Michael Leitzmann, Rafael Mikolajczyk et al. · 2026 · Exploratory Research in Clinical and Social Pharmacy